Botox for Facial Synkinesis(Targeted Chemodenervation)
Precision-guided therapy to relieve facial tightness, stop involuntary twitching, and restore a balanced smile.
Related case studies
What Is Botox for Facial Synkinesis?
Botulinum toxin (commonly known as Botox) is widely known for its cosmetic applications, but its most profound medical use is in the treatment of nerve disorders. In the context of facial paralysis, it is used as a highly precise, non-surgical tool called Targeted Chemodenervation.
When a facial nerve heals incorrectly after an injury, it often miswires, sending signals to the wrong muscles. This condition is called Synkinesis. For example, when you try to smile, your eye might forcefully squeeze shut, or the muscles in your neck (platysma) might strain downward, effectively fighting against your smile.
By injecting micro-doses of Botox directly into these overactive, miswired muscles, we can temporarily "turn down the volume" of the unwanted signals. This releases the tension, stops the spasms, and allows the correct muscles to function freely without resistance.
Conditions Treated with Botox
Chemodenervation is a cornerstone therapy for patients who have recovered some facial movement but are struggling with abnormal nerve regeneration. It is commonly used for:
What Botox for Synkinesis Can Relieve
- Improved Symmetry at Rest: Relaxes muscles that are constantly firing, pulling the face back into a neutral, balanced resting position.
- A Freer, Wider Smile: By weakening the depressor muscles (which pull down) and the neck bands, the smile muscles (zygomaticus) are finally allowed to pull upward unhindered.
- Reduction of Pain and Tightness: Synkinesis causes muscles to cramp from overuse. Botox breaks this cycle, offering significant relief from deep cheek and neck aches.
- Stopping Eye Narrowing: Carefully mapped injection around the eye can reduce involuntary narrowing or winking that occurs with eating, speaking, or smiling.
How Botox for Synkinesis Is Injected
Injecting Botox for facial paralysis is entirely different from cosmetic Botox. The goal is not to paralyze the face, but to finely tune the balance of power between dozens of tiny, interwoven muscles.
Dr. Jowett uses the movement examination and, when useful, electromyography (EMG) or ultrasound guidance to select muscles and doses. The aim is to concentrate treatment in the overactive pattern while preserving useful movement, but unwanted spread, temporary weakness, asymmetry, and other adverse effects remain possible. The map is reassessed as movement changes.
What the Evidence Shows
Targeted Botox is the medical workhorse for linked movement and tightness.
- It weakens the miswired muscles so the smile can move without the parking brake on.
- The effect lasts a few months and pairs best with neuromuscular retraining.
- It is not a cure. People who still feel trapped after repeated cycles may be candidates for selective neurectomy.
- Effects begin gradually over several days to about two weeks and typically last around three to four months, so sessions are generally spaced no more often than about every three months and many people settle into a maintenance schedule.
- Common targets on the affected side include the muscle around the eye, the platysma in the neck, the chin, and muscles around the mouth. The unaffected side is sometimes treated as well to improve symmetry.
- There is no standardized universal protocol. Doses and injection sites are individualized and reassessed at each visit based on how you responded, and EMG or ultrasound guidance may be used for deeper or hard-to-localize muscles.
- Side effects are usually mild and temporary: bruising or discomfort at the injection site, or short-lived weakness such as a drooping brow or eyelid, a lopsided smile, or a drooping lower lip if nearby muscles are affected.
- Botulinum toxin is generally avoided during pregnancy or breastfeeding, in certain neuromuscular disorders, with infection at the injection site, or with a known allergy to the product. Trouble swallowing, slurred speech, breathing difficulty, or generalized weakness after an injection is rare but needs immediate medical attention.
Why Choose Revitalis for Botox for Synkinesis?
Dr. Nate Jowett's facial nerve practice includes evaluation and treatment of synkinesis. Chemodenervation planning uses each patient's movement pattern, symptoms, and goals to select muscles and doses.
Botox often works best with facial palsy physical therapy—neuromuscular retraining uses the quieter months to practice smaller, more selective movement. When injections provide a reproducible benefit but repeated treatment is burdensome, selective neurectomy may offer a more durable option for carefully selected targets. Injection response helps map the pattern, but surgery is not identical to Botox and nerve regrowth, residual symptoms, or ongoing injections remain possible.
Common questions
Questions Patients Ask
Which muscles are injected for facial synkinesis?
Common targets include selected muscles around the eye, mouth, chin, and neck, but the combination varies. The goal is to reduce specific unwanted movement while preserving useful expression and oral competence.
How often will I need treatment?
Many patients return every three to four months, but interval and dose vary with response, goals, and rehabilitation. Some use fewer units or longer intervals after movement control improves.
Should Botox be combined with facial therapy?
Often, yes. Reducing strong co-contraction can create a window for practicing smaller, more selective movement with a therapist experienced in facial palsy.
How soon does it work, and how long does it last?
Effects begin gradually over several days to about two weeks and typically last around three to four months. Because the benefit fades, sessions are generally spaced no more often than about every three months, and many people settle into a maintenance schedule over time.
Is Botox for synkinesis the same as cosmetic Botox?
It is the same medication used for a different purpose. Cosmetic treatment softens wrinkles; treatment for synkinesis quiets specific overactive muscles that are pulling against your smile or tightening your neck, using individualized mapping rather than a standard pattern. There is no universal protocol - doses and sites are chosen for your movement pattern and reassessed each visit.
Can the unaffected side of my face be treated too?
Sometimes, yes. Treating selected muscles on the opposite side can improve overall symmetry when the stronger side overpowers the weaker one. Whether that helps you depends on your pattern and is decided at the assessment, not by default.
Are there reasons I should not have these injections?
Botulinum toxin is generally avoided during pregnancy or breastfeeding, in people with certain neuromuscular disorders, when there is infection at the injection site, or with a known allergy to the product. Tell your clinician about all your medications. Trouble swallowing, slurred speech, breathing difficulty, or generalized weakness after treatment is rare but needs immediate medical attention.
Answers are general and individualized at consultation.
Medical References & Evidence-Based Guidelines
- Effect of Weakening of Ipsilateral Depressor Anguli Oris on Smile Symmetry in Postparalysis Facial Palsy. Jowett N, Malka R, Hadlock TA. JAMA Facial Plast Surg. 2017 Jan 01; 19(1):29-33. PMID: 27658020.
- Weighting of Facial Grading Variables to Disfigurement in Facial Palsy. Banks CA, Jowett N, Hadlock CR, Hadlock TA. JAMA Facial Plast Surg. 2016 Jul 01; 18(4):292-8. PMID: 27124886.
- A General Approach to Facial Palsy. Jowett N. A General Approach to Facial Palsy. Otolaryngol Clin North Am. 2018 Dec; 51(6):1019-1031. PMID: 30119926.
- Contemporary Management of Bell Palsy. Jowett N, Hadlock TA. Facial Plast Surg. 2015 Apr; 31(2):93-102. PMID: 25958893.
- Pathogenesis, Diagnosis and Therapy of Facial Synkinesis: A Systematic Review and Clinical Practice Recommendations. Guntinas-Lichius O, Prengel J, Cohen O, et al. Front Neurol. 2022;13:1019554. PMID: 36438936.
- Botulinum Toxin Type A Injection in the Treatment of Postparetic Facial Synkinesis: An Integrative Review. Tavares H, Oliveira M, Costa R, et al. Am J Phys Med Rehabil. 2022;101(3):284-293. PMID: 35175961.
- Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis. de Jongh FW, Schaeffers AWMA, Kooreman ZE, et al. Eur Arch Otorhinolaryngol. 2023;280(4):1581-1592. PMID: 36544062.
- Rehabilitation of facial nerve palsy combining neuromuscular retraining and botulinum toxin A injection: a tertiary referral centre experience and a new working protocol proposal. Bonali M, Calvaruso F, Tozzi A, et al. Eur Arch Otorhinolaryngol. 2025;282(7):3757-3769. PMID: 40405023.
- Botulinum toxin in peripheral facial paralysis: systematic review and rehabilitation perspectives. Domínguez Ibáñez S. Eur J Phys Rehabil Med. 2026;62(4):380-392. PMID: 42517166.